Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$69.51 - $104.43 $173,844 - $261,179
2,501 New
2,501 $248,000
Q2 2023

Aug 09, 2023

BUY
$118.5 - $160.53 $53,443 - $72,399
451 Added 16.78%
3,139 $381,000
Q1 2023

May 01, 2023

BUY
$135.66 - $197.02 $114,361 - $166,087
843 Added 45.69%
2,688 $412,000
Q4 2022

Feb 06, 2023

BUY
$118.38 - $210.04 $14,797 - $26,255
125 Added 7.27%
1,845 $331,000
Q3 2022

Nov 07, 2022

SELL
$118.07 - $194.18 $5,903 - $9,709
-50 Reduced 2.82%
1,720 $203,000
Q2 2022

Aug 15, 2022

BUY
$117.13 - $176.59 $207,320 - $312,564
1,770 New
1,770 $253,000
Q1 2022

May 06, 2022

SELL
$126.46 - $235.05 $230,663 - $428,731
-1,824 Closed
0 $0
Q4 2021

Feb 07, 2022

SELL
$225.82 - $368.51 $81,069 - $132,295
-359 Reduced 16.45%
1,824 $447,000
Q3 2021

Nov 15, 2021

BUY
$221.9 - $484.47 $484,407 - $1.06 Million
2,183 New
2,183 $834,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $25.7B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Arete Wealth Advisors, LLC Portfolio

Follow Arete Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arete Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Arete Wealth Advisors, LLC with notifications on news.